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Background: New strains of meticillin-resistant Staphylococcus aureus (MRSA) may be
associated with changes in rates of disease or clinical presentation. Conventional typing
techniques may not detect new clonal variants that underlie changes in epidemiology or
clinical phenotype.
Aim: To investigate the role of clonal variants of MRSA in an outbreak of MRSA bacteraemia
at a hospital in England.
Methods: Bacteraemia isolates of the major UK lineages (EMRSA-15 and -16) from before
and after the outbreak were analysed by whole-genome sequencing in the context of
epidemiological and clinical data. For comparison, EMRSA-15 and -16 isolates from another
hospital in England were sequenced. A clonal variant of EMRSA-16 was identified at the
outbreak hospital and a molecular signature test designed to distinguish variant isolates
among further EMRSA-16 strains.
Findings: By whole-genome sequencing, EMRSA-16 isolates during the outbreak showed
strikingly low genetic diversity (P < 1  106, Monte Carlo test), compared with EMRSA-15
and EMRSA-16 isolates from before the outbreak or the comparator hospital, demon-
strating the emergence of a clonal variant. The variant was indistinguishable from thef Medicine, Brighton and Sussex Medical School, Falmer, East Sussex BN1 9PS, UK. Tel.: þ44 1273
(M.J. Llewelyn).
Elsevier Ltd on behalf of the Healthcare Infection Society. Open access under CC BY-NC-ND license.
R.R. Miller et al. / Journal of Hospital Infection 86 (2014) 83e8984ancestral strain by conventional typing. This clonal variant accounted for 64/72 (89%) of
EMRSA-16 bacteraemia isolates at the outbreak hospital from 2006.
Conclusions: Evolutionary changes in epidemic MRSA strains not detected by conventional
typing may be associated with changes in disease epidemiology. Rapid and affordable
technologies for whole-genome sequencing are becoming available with the potential to
identify and track the emergence of variants of highly clonal organisms.
ª 2013 The Authors. Published by Elsevier Ltd on behalf of the Healthcare Infection
Society. Open access under CC BY-NC-ND license.Introduction
Transmission of Staphylococcus aureus in hospitals, particu-
larly of meticillin-resistant S. aureus (MRSA), is a global health
challenge. Since its earliest detection, the epidemiology of
MRSAhasbeencharacterizedby the repeatedemergenceof new
clones that expand and then decline.1e3 In the UK, two clones
designated epidemic MRSA (EMRSA)-15 [corresponding to clonal
complex (CC)22 and multi-locus sequence type (ST)22] and
EMRSA-16 (also known as USA200 and corresponding to CC30,
ST36) became dominant in the 1990s, accounting for >95% of
nosocomial MRSA infection.4 The prevalence of both clones
began declining in around 2004, EMRSA-16 at a faster rate.5
In 2004, a large general teaching hospital in southern England
(Brighton) experienced a sudden increase in rates of MRSA
bacteraemia that persisted until 2007. Increases in hospital in-
fections are often attributed to poor infection control. How-
ever, outbreaks of MRSA infection may also be caused by the
importation of new strains.6e8 In the Brighton outbreak, con-
ventional typing methods failed to detect novel strains and
showed that the nationally prevalent EMRSA-15 and EMRSA-16
strains caused 92% of bacteraemias.9 A curious finding was
that although no new lineage appeared, EMRSA-16 dominated in
Brighton at a time when EMRSA-16 rates were falling nationally
in relation to EMRSA-15.4 Although failure in infection control
seemed possible, it was considered unlikely since it would have
most probably resulted in an increase in all bacterial strains.
In theory, clonal variants arising within epidemic MRSA
strains could, like new lineages, contribute to changes in
infection rate or severity. This has not been demonstrated to
date. Conventional approaches to typing of S. aureus [such as
typing of the spa gene or multi-locus sequence typing (MLST)]
are poorly discriminatory and would be unable to detect such
variation within EMRSA clones. Whole-genome sequencing has
the potential to detect subclones within dominant lineages of
MRSA and to reveal the genetic basis for clonal expansion and
virulence.7,10e13
We hypothesized that the emergence of a new clonal variant
within EMRSA-16 might account for the outbreak in Brighton.
Therefore the aim of this study was to investigate the outbreak
using bacterial whole-genome sequencing, in comparison with
control isolates from Oxford, where trends represented those
seen in the rest of the UK.
Methods
Setting, microbiological sampling and selection of
isolates for typing
Brighton and Sussex University Hospitals NHS Trust (BSUH) is
an 890-bed general and teaching hospital on the south coast ofEngland. Rates of MRSA bacteraemia reported to the Health
Protection Agency mandatory reporting scheme demonstrate
that the hospital experienced an outbreak of between 2004 and
2007 during which the peak rate of MRSA bacteraemia was
markedly higher and later than that seen in comparable hos-
pitals (Figure 1).
To test whether a clonal variant of EMRSA-15 or -16 might
explain the outbreak, we analysed two sets of bacteraemia
isolates collected at Brighton before (January 2000 to March
2001) and during (August 2006 to March 2007) the outbreak.
Isolates underwent spa-typing and meticillin-resistant isolates
were assigned as EMRSA-15 (spa-type t032) or EMRSA-16 (spa-
types t018) respectively. These isolates then underwent whole-
genome sequencing.9 As a control population, we whole-
genome-sequenced systematically collected bacteraemia and
carriage MRSA isolates from similar time-periods from the Ox-
ford University Hospital NHS Trust (OUH), a 1600-bed general
and teaching hospital in southern England, at which MRSA
bacteraemia rates were close to the national average across
the study period (Figure 1).
Based on the results of the whole-genome sequencing we
subsequently tested additional available Brighton isolates
collected in 2004, early in 2006 and from April 2007 to March
2011 using a molecular signature test (described below). In
total, 215 Brighton MRSA isolates from individual episodes of
bacteraemia between 2000 and 2011 were spa-typed, of which
82 (38%) were EMRSA-15 and 93 (45%) EMRSA-16, from which 32
and 38 whole-genome sequences were obtained respectively
(online-only Figure 1).
Whole-genome sequencing and bioinformatics
A full description of whole-genome sequencing and analysis
may be found in the online-only methods. Paired-end, indexed
libraries were produced for Illumina sequencing from 1.25 mg of
sample DNA. Read data were assembled de novo using Velvet,
and Staphylococcal Cassette Chromosome (SCC)mec types
were identified by comparison of Velvet assemblies with a
panel of type-representative SCCmec sequences.14 Reads from
EMRSA-16 and -15 isolates were mapped to lineage-specific
reference genomes as previously described.15e17 The evolu-
tionary history of each lineage was reconstructed using Clo-
nalFrame.18 Lineage-specific genetic insertions were identified
by mapping to a library of unique S. aureus sequences obtained
from GenBank. Sequence read data have been deposited with
the European Nucleotide Archive under accession ERP001489.
Molecular signature typing of EMRSA-16 isolates
Having identified the variant of EMRSA-16 in Brighton, a
molecular signature test was designed to identify this variant
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Figure 1. (A) Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia at Brighton and Sussex University Hospitals NHS Trust (BSUH;
red), Oxford University Hospitals (OUH; blue) and six other hospitals in South East England (SE; black) as reported to the Health Protection
Agency Mandatory Reporting Scheme for England and Wales (www.hpa.org.uk). The rate at Brighton rose from 21.4 episodes per 100,000
bed days (national average of 17.1) in 2001 to a peak of 47.1 in 2005, taking the hospital from 41st to 1st highest out of 167 hospitals in
England and Wales. (B) Estimated date and magnitude of MRSA bacteraemia rate for all hospitals in England and Wales between 2001 and
2011 derived from Mandatory Reporting Scheme data and bed occupancy (KH03 statistic) from NHS England. The peak MRSA bacteraemia
rate at Brighton was higher and later than at almost all other hospitals.
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sequenced. The assay targeted five single nucleotide poly-
morphisms (SNPs) (S1eS5) on the three branches ancestral to
the Brighton EMRSA-16 clonal variant (B1-B3 in Figure 2,
Supplementary Table I). SNPs were [position in MRSA252
reference, alleles (REF/variant)]: S1, nt 1138701 (A/G); S2, nt
486162 (C/T); S3, nt 1497289 (A/T); S4, nt 542018 (C/T); S5: nt
770373 (G/A). The test was validated using five positive control
isolates confirmed by whole-genome sequence data as clonal
variant isolates and 10 non-clonal controls. All genotypes
observed were either ancestral or the EMRSA-16 variant at all
five SNPs.Clinical profile of the outbreak
To assess the impact of the clonal variant on disease pre-
sentation, we compared age, sex, ward location and associated
routine laboratory data (haemoglobin, neutrophil count, total
white cell count, platelets, creatinine, urea, C-reactive pro-
tein and albumin) at the time of bacteraemia between the
clonal variant and all other episodes of MRSA bacteraemia at
Brighton during the study period. Differences were sought by t-
test or ManneWhitney U-test for parametrically and non-
parametrically distributed variables respectively and Fisher’s
exact test for differences in proportions. P  0.05 was
considered significant.Ethical approval
Isolate storage and data collection was approved in Brighton
by the BSUH Research and Development office as a service
evaluation, involving anonymized data from patient records
and not requiring formal ethical review. Oxford 1997e1998
isolates were collected from the routine microbiology labora-
tory and stored without personally identifying information.
Oxford 2003e2007 isolates were collected for epidemiological
studies covered by Statutory Instrument Regulations 2002 No.
1438, section (iii) ‘Communicable disease and other risks to
public health (Health Service Control of Patient Information)’
of Section 60 of the Health and Social Care Act and therefore
did not require research ethics committee approval.19Results
Use of whole-genome sequencing to define the
diversity of dominant MRSA clones during the
outbreak
For all MRSA isolates of spa-types t032 (CC22) and t018
(CC30), whole-genome sequencing confirmed membership of
the respective EMRSA lineage: all CC22 isolates carried type IV
SCCmec characteristic of EMRSA-15, and all but one CC30
isolate carried SCCmec II characteristic of EMRSA-16. The
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Figure 2. Phylogenetic trees for epidemic meticillin-resistant Staphylococcus aureus (EMRSA)-15 and EMRSA-16 isolates analysed from
Brighton (red) and Oxford (blue) during the study. The x-axis indicates date, where branch tips are the date of sampling and branches join
at the estimated dates of their presumed common ancestors. The EMRSA-16 tree is annotated to show branches labelled B1eB3 which are
ancestral to all outbreak isolates and include single nucleotide variants S1eS5 used in the molecular signature assay to identify clonal
variants. In addition, a 5.3 kb recombinational replacement was mapped to branch B1 and the three separate insertions of 20 kb of highly
similar non-reference sequences are indicated by BE.
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community-associated MRSA since it carried SCCmec V, was
genetically distinct and was ciprofloxacin sensitive; it was
excluded from further analysis.
Relationships within EMRSA-16 and EMRSA-15 groups were
reconstructed (Figure 2), using sampling times to place dates
on the phylogenetic tree (details in Supplementary methods).
The most recent common ancestor of EMRSA-16 strains in our
sample is estimated to have occurred in 1990 (95% credible
interval March 1989eFebruary 1991), coinciding closely with
the reported 1991 emergence of EMRSA-16 in the UK.20 There is
strong clustering of isolates in the EMRSA-16 tree with respect
to sampling time and location. The most recent common
ancestor of EMRSA-15 strains in our sample is estimated to have
occurred in 1994 (95% credible interval May 1993eOctober
1994) although EMRSA-15 was first described in English hospi-
tals in 1991.21,22
EMRSA-15 showed no dominant local clones and few clusters
with recent common ancestors (<3 years) (Figure 2). By
contrast, 5/14 (36%) early versus 22/24 (92%) late Brighton
EMRSA-16 genomes belonged to the largest recent genetic
cluster for their time-period, compared with 11/23 (48%) versus
13/25 (52%) early versus late Oxford genomes respectively. The
EMRSA-16 isolates from the Brighton 2006e2007 period showed
strikingly low molecular and lineage diversity, with the most
recent common ancestor of the 22 EMRSA-16 genomes forming a
single tight genetic cluster (termed the EMRSA-16 ‘variant’)
estimated to have existed in 2004 (95% credible interval
February 2004eJanuary 2005), coinciding with the rise in MRSA
bacteraemias in Brighton (Figure 1A). The genome of each
Brighton EMRSA-16 clonal variant differed from its nearest
neighbour by amedian of 7 (range: 0e22) mutations. Such close
genomic relationships are consistent with recent transmission
and clonal expansion, i.e. rapid, recent emergence.11 The for-
mation of such a large cluster so quickly is highly unlikely under
a standard coalescent model for the structure of an idealized
population (P < 1  106, by simulation).23
Contribution of the EMRSA-16 variant to the outbreak
To explore the contribution of the EMRSA-16 variant to the
outbreak, we tested all available EMRSA-16 isolates that had
not been whole-genome-sequenced using the SNP-based mo-
lecular signature test described above. Among all 215 Brighton
MRSA strains, 66 of the 93 EMRSA-16 isolates were identified as
the clonal variant. Among the isolates from 2000 to 2001, 0/15
of EMRSA-16 strains were the variant, in 2004 2/6 (33%) were
the variant, whereas after 2006, 64/72 EMRSA-16 strains (89%)
represented the clonal variant (see online-only Figure 2).
MRSA bacteraemias caused by the EMRSA-16 variant
occurred in patients of all ages and throughout the hospital.
There was no difference in age or sex of cases. However, the
proportion of MRSA bacteraemias caused by it differed be-
tween units with a greater proportion of clonal variant MRSA
bacteraemias in intensive care (19/33 MRSA bacteraemias) and
a lower proportion on the renal unit (7/46) (P < 0.001). After
adjustment for patient location, MRSA bacteraemia episodes
caused by the variant were associated with a significantly
higher total white cell count [difference þ4.0 (1.7e6.3  109/
L); P < 0.001] and neutrophil count [þ3.9 (1.7e6.0  109/L);
P < 0.001] than episodes caused by non-variant strains (non-
variant EMRSA-16, EMRSA-15 and other strains) with 40% ofvariant cases having neutrophil counts >15  109/L versus only
14% of the other strains. Platelet count was also higher in ep-
isodes caused by the variant [differenceþ62 (15e108 109/L);
P ¼ 0.009]. There was no significant difference in other lab-
oratory values including C-reactive protein (see online-only
tables).Genomic innovations associated with the EMRSA-16
clonal variant
We sought genomic events (mutation, homologous recom-
bination, gain or loss of gene content) on the branches of the
phylogeny ancestral to the variant (B1, B2, B3 in Figure 2) that
might explain its emergence via a selectively favoured change
in phenotype. Twenty-five point mutations (21 non-
synonymous, 11 non-synonymous substitutions on B3, the
branch immediately ancestral to the clonal expansion) were
identified across the three branches, including two non-
synonymous changes in ebh, a gene encoding a very large cell
wall-associated fibronectin-binding protein consistent with
patterns recently reported among EMRSA-16 strains in which
this gene was hypothesized to have an effect on virulence.12,24
A 5.3 kb homologous recombination event was detected on B2
(Figure 2) which shows high similarity to regions of the (phi)Sa3
family phage in the MRSA252 upstream of the regions encoding
the PantoneValentine Leucocidin (PVL) genes. In addition
3.2 kb of unique sequences (termed ‘BE’ in Figure 2) were
identified, variants of which had also inserted on other parts of
the EMRSA-16 tree. BE comprises part of a larger (w20 kb)
fragment of a phiNM4-like phage sequence whose position
could not be uniquely determined using short-read data.Discussion
Nosocomial infection rates, particularly those for MRSA
bacteraemia, are regarded as key indicators of infection con-
trol effectiveness.25 Not only do nosocomial infections have
significant impact on patient outcomes, but high rates may also
adversely affect reputation, leading to loss of revenue, and
further declines in quality.26 The emergence of novel pathogen
strains may influence disease epidemiology.6,7 One challenge
with clonal organisms such as S. aureus is that conventional
methods may fail to detect the emergence of novel variants
within major lineages, although it is plausible that such vari-
ants could influence rates and severity of disease. Advances in
microbial whole-genome sequencing make it possible for the
first time to detect variants of epidemic MRSA strains and
assess their impact.7
We applied whole-genome sequencing to investigate a
three-year hospital outbreak of MRSA bacteraemia and
demonstrated the emergence of a clonal variant of an epidemic
MRSA lineage that was undetectable using conventional geno-
typing. The appearance of the variant coincided with the onset
of the outbreak in 2004, and accounted for virtually all EMRSA-
16 isolates by the peak of the outbreak. MRSA bacteraemia
rates began to decline in 2007, possibly as a result of intensive
infection control measures, although no specific additional
intervention was made. The variant caused bacteraemias in
patients of all ages and throughout the hospital. It was most
prevalent in intensive care and gastroenterology units. Bac-
teraemias caused by the variant were associated with higher
R.R. Miller et al. / Journal of Hospital Infection 86 (2014) 83e8988neutrophil counts than other MRSA bacteraemias. There are
several possible explanations for this since the neutrophil
response to an infection depends on the immune status of the
patient and the source of the infection.
One explanation for the emergence of the variant is that one
or more genomic innovations may have conferred a selective
advantage leading to the clonal expansion. Although our data
do not definitively demonstrate that the clonal variant caused
the outbreak, the counter explanation that it was a feature of
the outbreak also indicates a transmission advantage of the
variant within it. Relatively small fitness advantages may have
a substantial impact on transmission, might be specific to a
local environment and could relate to several aspects of bac-
terial ecology, for example, the reported interaction between
microbial genetics and infection control practice in the selec-
tion of chlorhexidine resistance in MRSA.27,28 Other studies
have demonstrated the impact of new clones on the epidemi-
ology of S. aureus infection within specific hospital units; our
data indicate dissemination across different units within the
hospital.7,8 As whole-genome sequencing enters clinical prac-
tice we will come to understand how often new clonal variants
emerge within healthcare settings and how often this is asso-
ciated with clinically significant changes in disease phenotype
or transmission. Our failure to identify a specific genetic
explanation for the emergence of the variant is consistent with
reports describing the difficulty of establishing a causal link
retrospectively.18,29 The potential relationship between mu-
tations in ebh or the recombination events and higher neutro-
phil counts in bacteraemia caused by the clonal variant
requires further investigation.
Another potential explanation for the appearance of the
variant is a ‘founder effect’, in which a breakdown in infec-
tion control allowed the emergence of a randomly selected
strain which was not typical of the ancestral population.
However, it is unlikely that this would preferentially favour a
single clone and could alone explain the outbreak. Further-
more, it seems unlikely that a single MRSA lineage would have
expanded across the entire hospital by chance, surpassing
other prevalent MRSA lineages. Similarly, a lapse in infection
control specific to a single unit is not compatible with the
presence of the variant across the hospital. Staff were not
screened for MRSA during the period of the outbreak, so we
cannot exclude the possible involvement of one or more
healthcare workers in distributing the variant. Further studies
of the role of healthcare workers in nosocomial transmission
of S. aureus are warranted.
A limitation of this study is its dependence on archived
isolates: as such the sampling time-frame is interrupted.
Although this impedes precision in plotting the time-course of
the outbreak, the use of time-scaled phylogenies means that it
does not undermine the central observation.
Microbial whole-genome sequencing is providing insights
into the national and international spread of MRSA lin-
eages.11,12,30 This technology is entering clinical practice and
has the potential to be applied rapidly enough to influence
patient care.7,8 Our study demonstrates the emergence of a
clonal variant within a nosocomial epidemic MRSA lineage
associated with an outbreak. If, at the time of the outbreak, we
had been using whole-genome sequencing for routine surveil-
lance, the novel variant would have been recognized, allowing
targeted investigation of transmission routes and sources, and
the initiation of evidence-based control measures. This studydemonstrates the potential for whole-genome sequencing to
improve understanding of the epidemiology of MRSA within
hospitals.
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